InvestorsHub on MSN
Halozyme signs ENHANZE collaboration with Incyte for subcutaneous INCA033989 development
Halozyme Therapeutics (NASDAQ:HALO) has entered into a global collaboration and license agreement with Incyte (NASDAQ:INCY) ...
Daniel is a News Writer from the United Kingdom. Relatively new to the industry with just over three years of experience, he has focused on establishing himself in the gaming space, with bylines in ...
Hosted on MSN
‘It’s Something That We’re Keeping an Eye On’ REPO Developer Speaks About Possible Collaborations
REPO developer considers collaborations with other franchises in the future despite current busy slate. The game, known for physics-based interactions and humor, draws positive attention and viral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results